Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Trulieve Cannabis Corp. (TRLV : NYSE)

• Company Description    Trulieve Cannabis Corp. is a medical cannabis company and multi-state operator principally in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania and West Virginia. Trulieve Cannabis Corp. is based in TALLAHASSEE, Fla. Number of Employees: 5,000

• Price / Volume Information    Yesterday's Closing Price: $11.00 Daily Weekly Monthly 20 Day Moving Average: 1,822,962 shares Shares Outstanding: 192.57 (millions) Market Capitalization: $2,118.22 (millions) Beta: 52 Week High: $13.28 52 Week Low: $4.62 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.28% -12.86% 12 Week 36.48% 28.72% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3494 MARTIN HURST ROAD - TALLAHASSEE,FL 32312 USA ph: 850-298-8866 fax: - None http://www.trulieve.com

• General Corporate Information    Officers Kim Rivers - Chief Executive Officer Jan Reese - Chief Financial Officer Joy Malivuk - Chief Accounting Officer Thad Beshears - Director Peter Healy - Director Peer Information Trulieve Cannabis Corp. (BJCT) Trulieve Cannabis Corp. (CADMQ) Trulieve Cannabis Corp. (APNO) Trulieve Cannabis Corp. (UPDC) Trulieve Cannabis Corp. (IMTIQ) Trulieve Cannabis Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 89790E106 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/05/26 Share - Related Items Shares Outstanding: 192.57 Most Recent Split Date: (:1) Beta: Market Capitalization: $2,118.22 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.10 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.31 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/05/26

• Fundamental Ratios P/E Current FY Estimate: 35.87 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.76 Price/Cash Flow: - Price / Sales: 1.86 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -10.29% vs. Previous Quarter: -5.49% ROE 09/30/26 - - 06/30/26 - -4.24 03/31/26 - -6.92 ROA 09/30/26 - - 06/30/26 - -1.72 03/31/26 - -2.86 Current Ratio 09/30/26 - - 06/30/26 - 5.94 03/31/26 - 5.26 Quick Ratio 09/30/26 - - 06/30/26 - 3.98 03/31/26 - 3.31 Operating Margin 09/30/26 - - 06/30/26 - -3.95 03/31/26 - -6.93 Net Margin 09/30/26 - - 06/30/26 - -41.55 03/31/26 - -6.93 Pre-Tax Margin 09/30/26 - - 06/30/26 - -28.61 03/31/26 - 8.24 Book Value 09/30/26 - - 06/30/26 - 3.98 03/31/26 - - Inventory Turnover 09/30/26 - - 06/30/26 - 2.02 03/31/26 - 1.95 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.45 03/31/26 - 0.31 Debt-to-Capital 09/30/26 - - 06/30/26 - 31.06 03/31/26 - 23.86

Powered by Zacks Investment Research ©